Lumeris Launches Open Source COVID-19 Predictive Analytics Model to Help Prevent Unplanned Hospitalizations

Virtual Care Access Package is purpose-built to support providers in proactively identifying and managing high risk patients

ST. LOUIS–(BUSINESS WIRE)–Lumeris, an industry leader in value-based care, today announced that it has launched its Virtual Care Access Package solution to help payers and providers prevent hospitalizations during the COVID-19 crisis. The solution provides COVID-19 specific models, analytics and services that are designed to help organizations analyze system-wide COVID-19 impacts and more effectively identify, prioritize and engage with high risk patients.

Provider organizations are facing unprecedented resource constraints due to the COVID-19 pandemic and need solutions that leverage resources more efficiently,” said Michael Cousins, Chief Analytics Officer, at Lumeris. “We developed this predictive model to help PCPs and care teams proactively manage their high-risk patients and to potentially avoid hospitalizations. This model is easy to implement and can integrate into an organization’s existing EHR workflows to optimize resource capacity as needed.”

The Lumeris Virtual Care Access Package solution consists of advanced analytics and services to support organizations through the COVID-19 crisis and beyond:

  • Health System COVID-19 Diagnostic and Reporting to analyze potential clinical, financial and operational impacts of COVID-19 to the enterprise
  • Open source COVID-19 Predictive Analytics to identify, stratify and prioritize outreach and resources for those patients most at risk for hospitalization, including from COVID-19
  • COVID-19 Patient Engagement Solutions to expand care team capacity and proactively manage high risk patients through an existing EHR, the MyPCP™ Stay in Touch program and the deployment of Lumeris’ Population Health Managers

The MyPCP conversational AI outreach program, Stay in Touch, enables a new generation of patient engagement, helping expand primary care practice capacity to manage high risk patients. Using intelligent software to automate routine health checks, the texting outreach capability enables care teams to stay in touch with their patients virtually, prioritizing resources for those patients in most need.

In my practice, having the automated Stay in Touch program allows me and my care team to streamline how we engage with all of our patients, which is a game changer for success in population health,” said Dr. Alexander Rudoi, a primary care physician in St. Louis. “With this program we have a way to monitor our healthy patients while proactively outreaching to our highest risk patients, potentially avoiding hospitalizations and freeing up capacity during this pandemic.”

To read more information on the Lumeris Virtual Care Access Package, visit the Lumeris COVID-19 solution page.

ABOUT LUMERIS

Lumeris enables a new model for healthcare. As a value-based care managed services operator, Lumeris helps health systems and providers deliver extraordinary clinical and financial outcomes. With partners across the country, we align providers and payers with a proven model that coordinates operational processes, resources and technology to achieve high-quality, cost-effective care with satisfied consumers and engaged physicians.

Contacts

Marcus Gordon

678-358-4807

mgordon@lumeris.com

Staff

Recent Posts

Interactive Strength Inc. (Nasdaq: TRNR) Issues Year-End Update, Looks Ahead to 2025

AUSTIN, TEXAS / ACCESSWIRE / December 23, 2024 / Interactive Strength Inc. (Nasdaq:TRNR) ("TRNR" or…

15 minutes ago

Quest Diagnostics Upholds Strong Governance and Ethics With Robust Oversight, ESG Integration, and Comprehensive Risk Management

Originally published in Quest Diagnostics' 2023 Corporate Responsibility ReportNORTHAMPTON, MA / ACCESSWIRE / December 23,…

15 minutes ago

Phio Pharmaceuticals Announces Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

Marlborough, Massachusetts--(Newsfile Corp. - December 23, 2024) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO), a clinical-stage…

1 hour ago

ILiAD Biotechnologies Announces the Passing of Chief Operating Officer Ken Solovay

WESTON, Fla.--(BUSINESS WIRE)--ILiAD Biotechnologies, LLC (ILiAD), a clinical stage biotech company developing the world’s most…

3 hours ago

ILiAD Biotechnologies Announces the Passing of Chief Operating Officer Ken Solovay

WESTON, Fla.--(BUSINESS WIRE)--ILiAD Biotechnologies, LLC (ILiAD), a clinical stage biotech company developing the world’s most…

3 hours ago

Hallmark Adds Senior Executives to Enhance Customer Success and Strategic Partnerships

New leadership roles highlight Hallmark’s unique vendor-neutral approach to helping health systems build flexible, efficient,…

3 hours ago